TITLE

Induced Pluripotent Stem Cells

AUTHOR(S)
Wilson, Kitchener D.; Wu, Joseph C.
PUB. DATE
April 2015
SOURCE
JAMA: Journal of the American Medical Association;4/28/2015, Vol. 313 Issue 16, p1613
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the 2006 discovery of a method for creating induced pluripotent stem cells (iPSCs) by Takahashi and Shinya Yamanaka and colleagues, which won Yamanaka a Nobel Prize in 2012. Topics include the use of pluripotency to regenerate human organs and tissues, the time consumption and inconsistencies associated with iPSCs, and the use of iPSCs to develop and observe human genetic diseases.
ACCESSION #
102392450

 

Related Articles

  • REWIND STEM CELLS, THEN FAST FORWARD. Coghlan, Andy // New Scientist;12/22/2012, Vol. 216 Issue 2896/2897, p21 

    The article discusses the development of a process to transform adult cells into a stem cell state, focusing on induced pluripotent stem cells reverted by the researcher Shinya Yamanaka and a clinical trial planned by the biotechnology company Advanced Cell Technology Inc.

  • Japan stem-cell trial stirs envy. Reardon, Sara; Cyranoski, David // Nature;9/18/2014, Vol. 513 Issue 7518, p287 

    The article discusses the clinical trials of induced pluripotent stem (iPS) cells. It states that the iPS cells are created by using a patient's own tissue and by inserting them in an adult's DNA cells to reprogram the cells to an embryonic-like state. The therapy was pioneered by Shinya...

  • One Japan Stem Cell Institute Soars, One Struggles. Fox, Cynthia // Bioscience Technology;Jun2014, p1 

    The article reports on Center for iPS Cell Research and Application (CiRA) Nobel Prize winner and scientist Shinya Yamanaka in Japan. It mentions his statement over their proposed clinical trials on induced pluripotent stem cells (IPSCs). It also notes the problem of his sister institute, the...

  • As STAP Papers are Retracted, A Riken Researcher Mulls Stalling World-First Trial. Fox, Cynthia // Bioscience Technology;7/2/2014, p1 

    The article reports that Riken Center for Developmental Biology (CDB) researcher Masayo Takahashi is considering suspending a part of a world-first clinical trial of induced pluripotent stem cell (iPSC). Topics discussed include the "Nature" journal's retraction of Riken CDB researchers Haruko...

  • Nobel for stem cell trick...  // New Scientist;10/13/2012, Vol. 216 Issue 2886, p6 

    The article reports that cell scientists John Gurdon and Shinya Yamanaka were awarded the 2012 Nobel prize in physiology or medicine for their research into the reprogramming of mature cells into induced pluripotent stem cells (iPSCs) which can differentiate like embryonic stem cells.

  • Back to the future of stem cells.  // New Scientist;5/18/2013, Vol. 218 Issue 2917, p3 

    The article introduces a report within the issue about therapeutic cloning research, focusing on ethical and legal issues related to the use of stem cells and induced pluripotent stem cells (iPS).

  • Use of Induced Pluripotent Stem Cells in Dermatological Research. Dinella, Jason; Koster, Maranke I; Koch, Peter J // Journal of Investigative Dermatology;Aug2014, Vol. 134 Issue 8, pe23 

    The article discusses a study regarding the potential of induced pluripotent stem cells (iPSCs) to differentiate into any of the body's cell type such as somatic cells. Topics include the advantages, characterization, and limitations of iPSCs, the evaluation of genes with pluripotency, and the...

  • Embryo-like features of induced pluripotent stem cells defy legal and ethical boundaries. Meskus, Mianna; de Miguel Beriain, IƱigo // Croatian Medical Journal;dec2013, Vol. 54 Issue 6, p589 

    The article discusses emerging ethical aspects in stem cell science following the successes made in reprogramming adult cells to become induced pluripotent stem (IPS) cells in vitro as well as in vivo conditions. Topics discussed include advantages of reprogramming cells in disease modeling and...

  • Pushing the Reset Button: Chemical-Induced Conversion of Amniotic Fluid Stem Cells Into a Pluripotent State. Diecke, Sebastian; Wu, Joseph C // Molecular Therapy;Oct2012, Vol. 20 Issue 10, p1839 

    The authors discuss the study on the factor-free derivation of a pluripotent cell type using a c-Kit+ subpopulation of human amniotic fluid cells. The authors say that the potential of human embryonic stem cells (hESC) to differentiate into any cell type of the human body has raised the hope on...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics